Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation

Abstract

Multiple endocrine neoplasia type 1 is an autosomal dominant tumor syndrome. Manifestations include neoplasms of the parathyroid glands, enteropancreatic neuroendocrine cells, and the anterior pituitary gland. The MEN1 tumor suppressor gene encodes menin, a 610 amino acid nuclear protein without sequence homology to other proteins. To elucidate menin function, we used immunoprecipitation to identify interacting proteins. The NF-κB proteins p50, p52 and p65 were found to interact specifically and directly with menin in vitro and in vivo. The region of NF-κB proteins sufficient for binding to menin is the N-terminus. Furthermore, amino acids 305–381 of menin are essential for this binding. Menin represses p65-mediated transcriptional activation on NF-κB sites in a dose-dependent and specific manner. Also, PMA (phorbol 12-myristate 13-acetate)-stimulated NF-κB activation is suppressed by menin. These observations suggest that menin's ability to interact with NF-κB proteins and its modulation of NF-κB transactivation contribute to menin's tumor suppressor function.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL . 1999 Cell 96: 143–152

  • Baeuerle PA, Henkel T . 1994 Ann. Rev. Immunol. 12: 141–179

  • Baldwin AS . 1996 Ann. Rev. Immunol. 14: 649–681

  • Beauparlant P, Kwan I, Bitar R, Chou P, Koromilas AE, Sonenberg N, Hiscott J . 1994 Oncogene 9: 3189–3197

  • Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T . 1995 FASEB J. 9: 899–909

  • Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Lubensky IA, Zhuang Z, Guru SC, Manickham P, Olufemi SE, Chandrasekharappa SC, Crabtree JS, Kester MB, Kim YS, Heppner C, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Collins FS, Travis WD, Emmert-Buck MR . 1997 Hum. Mol. Genet. 6: 2285–2290

  • Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T . 1997 Proc. Nat. Acad. Sci. USA 94: 2927–2932

  • Ghosh G, van Duyne G, Ghosh S, Sigler PB . 1995 Nature 373: 303–310

  • Gilmore TD, Koedood M, Piffat KA, White DW . 1996 Oncogene 13: 1367–1378

  • Gobl AE, Berg M, Lopez-Egido JR, Ogberg K, Skogseid B, Westin G . 1999 Biochemica et Biophysica Acta 1447: 51–56

  • Goebel SU, Heppner C, Burns AL, Marx SJ, Spiegel AM, Zhuang Z, Lubensky IA, Gibril F, Jensen RT, Serrano J . 2000 J. Clin. Endocrinol. Metab. 85: 116–123

  • Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, Chandrasekharappa SC . 1998 Proc. Nat. Acad. Sci. USA 95: 1630–1634

  • Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi S-E, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ . 1997 Nat. Genet. 16: 375–378

  • Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . 1999 Mol. Cell. Biol. 19: 2690–2698

  • Huxford T, Huang D-B, Malek S, Ghosh G . 1998 Cell 95: 759–770

  • Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN . 2001 Proc. Nat. Acad. Sci. USA 98: 3837–3842

  • Kaelin Jr. WG, Pallas DC, DeCaprio JA, Kaye FC, Livingston DM . 1991 Cell 64: 521–532

  • Kingston RE . 1999 Nature 399: 199–200

  • Kumar S, Gélinas C . 1993 Proc. Nat. Acad. Sci. USA 90: 8962–8966

  • La Rosa FA, Pierce JW, Sonenshein GE . 1994 Mol. Cell. Biol. 14: 1039–1044

  • LeClair KP, Blanar MA, Sharp PA . 1992 Proc. Nat. Acad. Sci. USA 89: 8145–8149

  • Malek S, Huxford T, Ghosh G . 1998 J. Biol. Chem. 273: 25427–25435

  • Marx SJ . 2001 Multiple endocrine neoplasia type 1. In Metabolic Basis of Inherited Diseases 8th Ed, Scriver CS et al McGraw-Hill, New York pp. 943–966

    Google Scholar 

  • May MJ, Gosh S . 1997 Cancer Biol. 8: 63–73

  • Pahl HL . 1999 Oncogene 18: 6853–6866

  • Perkins ND, Edwards CS, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ . 1993 EMBO J. 12: 3551–3558

  • Ravi R, Mookerjee B, van Hensbergen Y, Bedi GC, Giordano A, El-Deiry WS, Fuchs EJ, Bedi A . 1998 Cancer Res. 58: 4531–4536

  • Ray A, Prefontaine KE . 1994 Proc. Nat. Acad. Sci. USA 91: 752–756

  • Rayet B, Gelinas C . 1999 Oncogene 18: 6938–6947

  • Siebenlist U, Franzoso G, Brown K . 1994 Ann. Rev. Cell. Biol. 10: 405–455

  • Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P . 1993a EMBO J. 12: 3879–3891

  • Stein B, Cogswell PC, Baldwin AS . 1993b Mol. Cell. Biol. 13: 3964–3974

  • Thanos D, Maniatis T . 1995 Cell 80: 529–532

  • Valle MA, Kester MB, Burns AL, Marx SJ, Spiegel AM, Shiloach J . 2001 Cytotechnology in press

  • Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T . 1998 Mol. Cell. 1: 507–518

  • Wolberger C . 1998 Curr. Opin. Genetics Dev. 8: 552–559

  • Wulczyn FG, Krappmann D, Scheidereit C . 1996 J. Mol. Med. 74: 749–769

  • Zhong HH, Voll RE, Gosh S . 1998 Mol. Cell. 1: 661–671

Download references

Acknowledgements

We thank Dr Paul K Goldsmith (NIDDK) for purified menin antibodies, Dr George Poy (NIDDK) for DNA sequencing and Dr Regina M Collins (NIDDK) for cell culture assistance. Furthermore, we thank Dr Ulrich Siebenlist (NIAID) for helpful discussion and providing the GST-50 construct and Dr Nancy R Rice (NCl) for the p100 construct.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heppner, C., Bilimoria, K., Agarwal, S. et al. The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20, 4917–4925 (2001). https://doi.org/10.1038/sj.onc.1204529

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204529

Keywords

This article is cited by

Search

Quick links